Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to news |u:www.enterprize.cam.ac.uk.  Search for news |u:www.enterprise.cam.ac.uk instead.
101 - 120 of 175 search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. ISOLDE: Building High Quality Macromolecular Models into Low…

    https://www.enterprise.cam.ac.uk/reagents/isolde-building-high-quality-macromolecular-models-into-low-resolution-experimental-maps/
    Thumbnail for ISOLDE: Building High Quality Macromolecular Models into Low Resolution Experimental Maps – Cambridge Enterprise 26 Oct 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. ISOLDE: Building High Quality Macromolecular Models into Low Resolution Experimental Maps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed) designed to ease the task
  3. Porotech: Rapid progress towards brighter, sharper and more vivid…

    https://www.enterprise.cam.ac.uk/case-studies/porotech-rapid-progress-towards-brighter-sharper-and-more-vivid-micro-led-displays-for-everyone/
    Thumbnail for Porotech: Rapid progress towards brighter, sharper and more vivid micro-LED displays for everyone – Cambridge Enterprise 10 Aug 2023: Co-founded by Dr Tongtong Zhu (CEO), Dr Yingjun Liu (CTO) and Professor Rachel Oliver (CSO), Porotech had hit upon and developed a new class of porous gallium nitride (GaN) semiconductor ... This latest funding will accelerate our work to ensure that
  4. The Chris Abell Postdoc Business Plan Competition – Cambridge…

    https://www.enterprise.cam.ac.uk/for-the-university/start-a-company-or-social-enterprise/the-chris-abell-business-plan-competition/
    Thumbnail for The Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 26 Oct 2023: MiniCPC led by Molly Haugen (Department of Engineering). New Battery Co. led by Ismail Sami (Department of Materials Science and Metallurgy).
  5. PervasID secures £720k investment – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/pervasid-secures-720k-investment/
    Thumbnail for PervasID secures £720k investment – Cambridge Enterprise 22 Feb 2023: We are pleased to announce that Cambridge Enterprise, the University of Cambridge Enterprise Fund IV, managed by Parkwalk, and Cambridge Innovation Capital...
  6. How we use your personal information - University of Cambridge staff…

    https://www.enterprise.cam.ac.uk/privacy-compliance/data-protection/privacy-university-cambridge-staff-students/
    1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – University of Cambridge staff and students. How we use your personal information – University of Cambridge staff and students. This policy
  7. How we use your personal information - subscribers to digital…

    https://www.enterprise.cam.ac.uk/privacy-compliance/data-protection/privacy-subscribers-to-digital-newsletters-and-updates/
    1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – subscribers to digital newsletters and updates. How we use your personal information – subscribers to digital newsletters and updates. This
  8. New agreement with Cambridge spin-out PredictImmune lets SLE join…

    https://www.enterprise.cam.ac.uk/news/new-agreement-with-university-spin-out-predictimmune-allows-product-pipeline-to-include-systemic-lupus-erythematosus/
    Thumbnail for New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline – Cambridge Enterprise 22 Feb 2023: 19 September 2019. New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline. ... The expanded agreement will allow PredictImmune to evolve its product development pipeline, accelerating its commercial offering into this new therapeutic
  9. Aqdot closes £2.55m funding round – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/aqdot-closes-2-55m-funding-round/
    Thumbnail for Aqdot closes £2.55m funding round – Cambridge Enterprise 22 Feb 2023: The continued support from our seed investors and interest from new investors demonstrates the robustness of our technology and underlines the rapid progress Aqdot is making. ... Tim Wright, CEO at Aqdot, said “the continued support from our seed
  10. Oxford-Cambridge-joint-investor-event

    https://www.enterprise.cam.ac.uk/news/oxbridge-research-city-investors/
    Thumbnail for Oxford-Cambridge-joint-investor-event 22 Feb 2023: The latest technologies stemming from research at Oxford and Cambridge were presented to investors at an event held at the Royal Society of Chemistry.
  11. Cambridge spin-out Qkine secures additional £550k investment –…

    https://www.enterprise.cam.ac.uk/news/spin-out-qkine-secures-additional-550k/
    Thumbnail for Cambridge spin-out Qkine secures additional £550k investment – Cambridge Enterprise 22 Feb 2023: Stem cells are revolutionising medicine by enabling new approaches for disease modelling, precision medicine and development of new therapeutics. ... The need for quality and reproducibility in stem cell biology and exciting new areas such as organoids
  12. Cambridge Enterprise announces 2010 results – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-announces-2010-results/
    Thumbnail for Cambridge Enterprise announces 2010 results – Cambridge Enterprise 23 Feb 2023: One third of this year’s consultancy projects were from new academic consultants. ... Cambridge Enterprise also invests intellectual property and cash to create new companies and ventures based on Cambridge research.
  13. Discovery Fund makes latest investment in Sphere Fluidics – Cambridge …

    https://www.enterprise.cam.ac.uk/news/discovery-fund-makes-its-latest-investment/
    Thumbnail for Discovery Fund makes latest investment in Sphere Fluidics – Cambridge Enterprise 23 Feb 2023: Share:. The Discovery Fund recently made its second investment in a new University spin-out that is developing water droplets that serve as ‘miniature test tubes’. ... Dr Geraldine Rodgers. Dr Frank Craig has been recruited as CEO, and the
  14. /Where ideas thrive Our 2021 story Highlights from our ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge-Enterprise-Annual-Review-2021-compressed.pdf
    5 Jul 2023: Apollo is now advancing into clinical development as well as identifying new programmes. ... profi le. Evidence included scientifi c papers, government reports, and local news articles.
  15. Cambridge Enterprise announces 2012 results – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-announces-2012-results/
    Thumbnail for Cambridge Enterprise announces 2012 results – Cambridge Enterprise 22 Feb 2023: sectors, where they will be used to model a range of diseases and accelerate the development of new treatments. ... This funding is helping develop new therapies and treatments for conditions which affect millions worldwide, including liver disease,
  16. Spin-out Fluidic Analytics closes $31m funding round – Cambridge…

    https://www.enterprise.cam.ac.uk/news/fluidic-analytics-closes-31m-funding-round/
    Thumbnail for Spin-out Fluidic Analytics closes $31m funding round – Cambridge Enterprise 22 Feb 2023: technology. Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to ... Joining the round as new investors
  17. Cambridge Epigenetix launches its first product, TrueMethyl –…

    https://www.enterprise.cam.ac.uk/news/cambridge-epigenetix-launches-its-first-product/
    Thumbnail for Cambridge Epigenetix launches its first product, TrueMethyl – Cambridge Enterprise 22 Feb 2023: Trials of the kits conducted at leading research centres around the world have already begun to yield new insights into genome function and highlighted the advantages of TrueMethyl relative to traditional ... Consequently, this pioneering analytical
  18. Annual Review 2022 Contents Foreword From the Chair Investment ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf
    3 Jul 2023: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.
  19. DefiniGEN raises £1.5M in follow-on funding – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/definigen-raises-1-5m-in-follow-on-funding/
    Thumbnail for DefiniGEN raises £1.5M in follow-on funding – Cambridge Enterprise 22 Feb 2023: The new funding will help drive DefiniGEN to profitability and enable the Company to achieve the following:. ... We are delighted to have raised the funds that will allow us to deliver new market-leading products to our customers and assist them in
  20. Accelerated Materials wins The Chris Abell Postdoc Business Plan…

    https://www.enterprise.cam.ac.uk/news/accelerated-materials-wins-business-plan-competition/
    Thumbnail for Accelerated Materials wins The Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 22 Feb 2023: The Postdoc Business Plan Competition was won by Accelerated Materials which helps businesses create innovative products with nanomaterials
  21. Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/
    Thumbnail for Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise 22 Feb 2023: We are delighted to announce that Cambridge Enterprise and the Parkwalk Opportunities Fund and have completed an investment in PredictImmune Limited, a...

Refine your results

Format

Related searches for news |u:www.enterprise.cam.ac.uk

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.